GYNECOLOGIC CANCERS

August 4th 2024

IMMN-001 significantly extended overall survival in patients with advanced ovarian cancer when combined with standard chemotherapy, according to phase 2 trial results.

August 1st 2024

Dostarlimab plus chemotherapy has been approved for the treatment of all forms of advanced endometrial cancer, including mismatch repair-deficient and microsatellite stable tumors.

July 26th 2024

Findings from the phase 2 NeoPembrOV study supported the addition of pembrolizumab to neoadjuvant chemotherapy before surgery in high-grade serous ovarian cancer.

July 24th 2024

Bhavana Pothuri, MD, discussed the importance of testing and accessing treatment for patients with endometrial cancer.